<DOC>
	<DOCNO>NCT00777023</DOCNO>
	<brief_summary>Depomed 's Gabapentin Extended Release investigational , extended release formulation gabapentin study treatment hot flash postmenopausal woman</brief_summary>
	<brief_title>Study Gabapentin Extended Release ( G-ER ) Treatment Vasomotor ( Hot Flashes/Hot Flushes ) Symptoms Postmenopausal Women .</brief_title>
	<detailed_description>The primary study objective ass efficacy G-ER dose either follow regimen : G-ER 1200mg daily ( single evening dose ) G-ER 1800mg daily ( dose asymmetrically ; 600mg AM/1200mg PM ) compare placebo reduce average daily frequency severity score moderate severe hot flash postmenopausal woman 4 week 12 week treatment stable dose , compare baseline week .</detailed_description>
	<mesh_term>Hot Flashes</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>1 . Postmenopausal woman age 18 70 year experience ≥7 moderate severe hot flash per day ( ≥50 per week ) accompany sweat previous 30 day longer . 2 . Had amenorrhea ≥12 month , amenorrhea 6 12 month serum folliclestimulating hormone ( FSH ) level &gt; 40 mIU/mL , ≥6 week postsurgical bilateral oophorectomy without hysterectomy . 3 . Willing discontinue follow : vaginal hormonal product ; transdermal oral estrogen estrogen/progestin combination ; intrauterine progestin ; progestin implant ; injectable estrogen ; topical progesterone cream . 4 . Had daily average ≥7 moderate severe hot flash complete ≥4 day diary entry baseline week randomize . 5 . If treated antidepressant , could change drug dos past month . Other Inclusions apply . 1 . Patient treat gonadotrophin release hormone agonist , antiestrogens , aromatase inhibitor within 2 month prior study entry . 2 . Patient treat estrogen pellet progestin injectable drug within 6 month prior study entry . 3 . Patient experience nighttime hot flash work night shift regular basis . 4 . Patient concurrently treat gabapentin indication . If patient use gabapentin treatment hot flash , could screen 7day washout period provide hot flash return . 5 . Patient previously experience doselimiting adverse effect prevent titration gabapentin effective dose . 6 . Patient hypersensitivity gabapentin . 7 . Patient immunocompromised state . 8 . Patient malignancy basal cell carcinoma within 2 year prior study entry . 9 . Patient gastric reduction surgery , severe chronic diarrhea , chronic constipation , uncontrolled irritable bowel syndrome , uncontrolled inflammatory bowel disease , unexplained weight loss . 10 . Patient clinically significant abnormal chemistry hematology result , calculate glomerular filtration rate &lt; 60 mL/min . 11 . Patient history substance abuse within year prior study entry . 12 . Patient concurrently take morphine . 13 . Patient history chronic hepatitis B C , hepatitis within 3 month prior study entry , history human immunodeficiency virus . Other Exclusions apply .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Hot Flashes</keyword>
	<keyword>Hot Flushes</keyword>
	<keyword>Postmenopausal symptom</keyword>
	<keyword>Vasomotor symptom</keyword>
</DOC>